Home SpiroConnect Where to Buy Manuals Certificates Privacy Policy MedChip Solutions Covid-19 Response Contact Us
Home SpiroConnect Where to Buy Manuals Certificates Contact Us MedChip Solutions Covid-19 Response

Technological innovations for respiratory diagnostics

MedChip Solutions Covid-19 Response

Covid-19 Response Image

Spirometry should not be performed if the patient has any symptoms of COVID-19 infection at the time of the test, or if they are known to have recently been in contact (within previous 10 days) with a confirmed case1.

MedChip Solutions recommends that a spirometry test using the SpiroConnect®, should only be performed using a bacterial/viral spirometry filter. These should be purchased from an authorised SpiroConnect® distributor to ensure they fit the device correctly.

After each use the unit should be wiped down with an alcohol infused wipe or other medically approved anti-viral wipes as described in the SpiroConnect® Operators Manual.

The single use pulmonary filter should be safely disposed of immediately after the test by a clinician wearing appropriate personal protective equipment (PPE).

Even though the SpiroConnect® directs air downwards away from the clinician's face, it is recommended that a clinician is wearing appropriate PPE that limits aerosolized droplet acquisition2 as the patient may cough after performing spirometry.

The Bluetooth connectivity allows the clinician to remain at a safe distance from the patient throughout the test and to be isolated from the patient, preferably behind a screen, in case of a coughing event. Enhanced cleaning of the testing space should be carried out such as wiping down surfaces with appropriate cleaners2.

If available, a room with mechanical air circulation should be used or a room where other ways of ventilation are possible (e.g. opening windows). Ideally this should be in the region of 6 room air changes per hour3.

The MedChip Solutions Covid-19 Response is based on the ATS guidance and the ARTP document "Risk Minimisation in Spirometry Re-start" by Martin Allen4. Which includes:

PCRS Spirometry in Primary Care - Guidance on reinstating spirometry in England

ARTP Statement for the NHS NATIONAL RESPIRATORY PROGRAMME Task and Finish Group Recommendations for undertaking risk-managed spirometry

Covid19 advice may be updated by the Medical Bodies and Governments. It is vital to always act in line with the latest advice and any local Risk Assessment.

References:

1. ARTP (Association for Respiratory Technology & Physiology) Statement for the NHS NATIONAL RESPIRATORY PROGRAMME Task and Finish Group Recommendations for undertaking risk-managed spirometry.

2. Meredith C. McCormack, MD MHS, David A. Kaminsky, MD, 2020 members of the ATS Proficiency Standards for Pulmonary Function Testing Committee.

3. ARTP (Association for Respiratory Technology & Physiology) Statement for the NHS NATIONAL RESPIRATORY PROGRAMME Task and Finish Group Recommendations for undertaking risk-managed spirometry.

4. www.artp.org.uk/ write/ MediaUploads/ Standards/ COVID19/ARTP_PCRS_spiro_re-start_FINAL2.pdf